Beacon Financial Group Trimmed Its Johnson & Johnson (JNJ) Holding; Xoma (XOMA) Shorts Raised By 0.24%

XOMA Corporation (NASDAQ:XOMA) Logo

Beacon Financial Group decreased Johnson & Johnson (JNJ) stake by 19.82% reported in 2017Q4 SEC filing. Beacon Financial Group sold 17,172 shares as Johnson & Johnson (JNJ)’s stock declined 9.21%. The Beacon Financial Group holds 69,448 shares with $9.70 million value, down from 86,620 last quarter. Johnson & Johnson now has $347.35B valuation. The stock increased 1.08% or $1.38 during the last trading session, reaching $129.48. About 6.40 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since April 10, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

Xoma Corporation (NASDAQ:XOMA) had an increase of 0.24% in short interest. XOMA’s SI was 591,800 shares in April as released by FINRA. Its up 0.24% from 590,400 shares previously. With 104,300 avg volume, 6 days are for Xoma Corporation (NASDAQ:XOMA)’s short sellers to cover XOMA’s short positions. The SI to Xoma Corporation’s float is 9.79%. The stock decreased 0.57% or $0.12 during the last trading session, reaching $20.78. About 150,035 shares traded. XOMA Corporation (NASDAQ:XOMA) has risen 184.45% since April 10, 2017 and is uptrending. It has outperformed by 172.90% the S&P500.

Among 7 analysts covering Xoma Limited (NASDAQ:XOMA), 2 have Buy rating, 0 Sell and 5 Hold. Therefore 29% are positive. Xoma Limited has $49.0 highest and $1.50 lowest target. $27.83’s average target is 33.93% above currents $20.78 stock price. Xoma Limited had 23 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was downgraded by Piper Jaffray to “Neutral” on Wednesday, July 22. The company was upgraded on Tuesday, September 5 by Wedbush. H.C. Wainwright maintained the shares of XOMA in report on Thursday, January 18 with “Buy” rating. The firm has “Buy” rating by Wedbush given on Tuesday, December 19. The stock of XOMA Corporation (NASDAQ:XOMA) has “Neutral” rating given on Monday, March 27 by Wedbush. H.C. Wainwright maintained the shares of XOMA in report on Thursday, August 10 with “Buy” rating. The stock of XOMA Corporation (NASDAQ:XOMA) has “Hold” rating given on Monday, August 14 by Wedbush. The stock of XOMA Corporation (NASDAQ:XOMA) earned “Buy” rating by H.C. Wainwright on Tuesday, October 17. On Thursday, July 23 the stock rating was downgraded by Jefferies to “Hold”. H.C. Wainwright maintained XOMA Corporation (NASDAQ:XOMA) on Tuesday, November 7 with “Buy” rating.

XOMA Corporation discovers, develops, and commercializes antibody therapeutics in the United States, Europe, and the Asia Pacific. The company has market cap of $173.14 million. The companyÂ’s product candidates include X358, a human negative allosteric modulating insulin receptor antibody that is in Phase II proof-of-concept study for the treatment of patients with hypoglycemia due to congenital hyperinsulinism and hypoglycemia in post-bariatric surgery patients; X213, a allosteric inhibitor for the treatment of prolactinoma and anti-psychotic-induced hyperprolactinemia; and X129, a potent fragment of a monoclonal antibody for the treatment of patients with acute severe hypoglycemia. It has a 28.54 P/E ratio. The Company’s preclinical product candidates comprise interleukin 2 for the treatment of metastatic melanoma and renal cell carcinoma; and anti-parathyroid receptor, a G-protein-coupled receptor for the treatment of hyperparathyroidism and humoral hypercalcemia of malignancy.

Investors sentiment increased to 0.87 in Q4 2017. Its up 0.04, from 0.83 in 2017Q3. It is positive, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. Stearns Financial Gru holds 1.6% or 48,051 shares in its portfolio. Waters Parkerson Lc has invested 1.89% in Johnson & Johnson (NYSE:JNJ). Mcmillion Capital Management stated it has 36,525 shares. Haverford Tru Co has 3.08% invested in Johnson & Johnson (NYSE:JNJ). 37,510 were accumulated by Ar Asset. The Minnesota-based Stillwater Invest Mgmt Limited Liability Company has invested 2.75% in Johnson & Johnson (NYSE:JNJ). Florida-based Cap City Trust Communication Fl has invested 2.22% in Johnson & Johnson (NYSE:JNJ). Donaldson Capital Management Ltd Co holds 3.59% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 7,295 shares. Great Lakes Advsrs, a Illinois-based fund reported 147,394 shares. 1,640 are held by Qv Investors. Captrust has invested 1.14% in Johnson & Johnson (NYSE:JNJ). Premier Asset Limited Liability Co holds 0.09% or 2,749 shares. Smithbridge Asset Mgmt Inc De holds 3.66% or 41,443 shares in its portfolio. Eos Management LP stated it has 0.43% of its portfolio in Johnson & Johnson (NYSE:JNJ). Ycg Ltd Liability Company holds 14,347 shares or 0.49% of its portfolio.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on April, 17. They expect $2.01 earnings per share, up 9.84% or $0.18 from last year’s $1.83 per share. JNJ’s profit will be $5.39 billion for 16.10 P/E if the $2.01 EPS becomes a reality. After $1.74 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 15.52% EPS growth.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson has $170.0 highest and $90 lowest target. $137.17’s average target is 5.94% above currents $129.48 stock price. Johnson & Johnson had 92 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was upgraded by Barclays Capital on Tuesday, December 1 to “Overweight”. Citigroup maintained Johnson & Johnson (NYSE:JNJ) rating on Monday, October 23. Citigroup has “Buy” rating and $149 target. The firm has “Buy” rating by Argus Research given on Wednesday, April 20. The firm has “Buy” rating given on Wednesday, July 19 by UBS. On Thursday, July 14 the stock rating was maintained by Jefferies with “Hold”. The firm earned “Overweight” rating on Wednesday, April 20 by Barclays Capital. The rating was maintained by Citigroup on Tuesday, February 27 with “Neutral”. As per Tuesday, June 13, the company rating was maintained by Cowen & Co. BMO Capital Markets maintained it with “Buy” rating and $145.0 target in Thursday, August 31 report. The firm has “Hold” rating by Stifel Nicolaus given on Wednesday, October 18.

Since February 15, 2018, it had 0 insider purchases, and 1 sale for $20.17 million activity. Stoffels Paulus also sold $20.17M worth of Johnson & Johnson (NYSE:JNJ) on Thursday, February 15.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart